SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: Secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes

EJM van Bommel; Frank Geurts; MHA Muskiet; Adrian Post; SJ Bakker; AHJ Danser; DJ Touw; M van Berkel; MHH Kramer; M Nieuwdorp; E Ferrannini; JA Joles; Ewout Hoorn; DH van Raalte

doi:10.1042/cs20201274

SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: Secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes

EJM van Bommel, Frank Geurts, MHA Muskiet, Adrian Post, SJ Bakker, AHJ Danser, DJ Touw, M van Berkel, MHH Kramer, M Nieuwdorp, E Ferrannini, JA Joles, Ewout Hoorn, DH van Raalte

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

12 Citations (Scopus)

Original language	English
Pages (from-to)	3107-3118
Number of pages	12
Journal	Clinical Science
Volume	134
Issue number	23
DOIs	https://doi.org/10.1042/cs20201274
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1042/cs20201274

Cite this

van Bommel, EJM., Geurts, F., Muskiet, MHA., Post, A., Bakker, SJ., Danser, AHJ., Touw, DJ., van Berkel, M., Kramer, MHH., Nieuwdorp, M., Ferrannini, E., Joles, JA., Hoorn, E., & van Raalte, DH. (2020). SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: Secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes. Clinical Science, 134(23), 3107-3118. https://doi.org/10.1042/cs20201274

@article{3304827f64514c6883d25b26332026ea,

title = "SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: Secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes",

author = "{van Bommel}, EJM and Frank Geurts and MHA Muskiet and Adrian Post and SJ Bakker and AHJ Danser and DJ Touw and {van Berkel}, M and MHH Kramer and M Nieuwdorp and E Ferrannini and JA Joles and Ewout Hoorn and {van Raalte}, DH",

year = "2020",

doi = "10.1042/cs20201274",

language = "English",

volume = "134",

pages = "3107--3118",

journal = "Clinical Science",

issn = "0143-5221",

publisher = "Portland Press, Ltd.",

number = "23",

}

van Bommel, EJM, Geurts, F, Muskiet, MHA, Post, A, Bakker, SJ, Danser, AHJ, Touw, DJ, van Berkel, M, Kramer, MHH, Nieuwdorp, M, Ferrannini, E, Joles, JA, Hoorn, E & van Raalte, DH 2020, 'SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: Secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes', Clinical Science, vol. 134, no. 23, pp. 3107-3118. https://doi.org/10.1042/cs20201274

SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: Secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes. / van Bommel, EJM; Geurts, Frank; Muskiet, MHA et al.
In: Clinical Science, Vol. 134, No. 23, 2020, p. 3107-3118.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: Secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes

AU - van Bommel, EJM

AU - Geurts, Frank

AU - Muskiet, MHA

AU - Post, Adrian

AU - Bakker, SJ

AU - Danser, AHJ

AU - Touw, DJ

AU - van Berkel, M

AU - Kramer, MHH

AU - Nieuwdorp, M

AU - Ferrannini, E

AU - Joles, JA

AU - Hoorn, Ewout

AU - van Raalte, DH

PY - 2020

Y1 - 2020

U2 - 10.1042/cs20201274

DO - 10.1042/cs20201274

M3 - Article

SN - 0143-5221

VL - 134

SP - 3107

EP - 3118

JO - Clinical Science

JF - Clinical Science

IS - 23

ER -